Advertisement
Screener

EPIZYME, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations

EPIZYME, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations

EPIZYME, INC. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$30.34 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2018-05-08

  • EPIZYME, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-03-31 was -$30.34M.
  • EPIZYME, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-12-31 was -$30.39M.
  • EPIZYME, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-09-30 was -$38.89M.
  • EPIZYME, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was -$17.91M.
  • EPIZYME, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2017 was -$120.43M.
  • EPIZYME, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$96.37M.
  • EPIZYME, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$72.92M.
  • EPIZYME, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$35.36M.
Period endNet Cash Provided by (Used in) Operating Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month
2018-03-31-$30.34M
10-Q · filed 2018-05-08
-$60.73M
derived: sum of 2 quarters · filed 2018-05-08
-$99.63M
derived: sum of 3 quarters · filed 2018-05-08
-$117.54M
derived: sum of 4 quarters · filed 2018-05-08
2017-12-31-$30.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
-$69.28M
derived: sum of 2 quarters · filed 2018-03-13
-$87.20M
derived: sum of 3 quarters · filed 2018-03-13
-$120.43M
10-K · filed 2018-03-13
2017-09-30-$38.89M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01
-$56.81M
derived: sum of 2 quarters · filed 2017-11-01
-$90.04M
10-Q · filed 2017-11-01
-$111.02M
derived: sum of 4 quarters · filed 2018-05-08
2017-06-30-$17.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07
-$51.15M
10-Q · filed 2017-08-07
-$72.12M
derived: sum of 3 quarters · filed 2018-05-08
-$97.37M
derived: sum of 4 quarters · filed 2018-05-08
2017-03-31-$33.23M
10-Q · filed 2018-05-08
-$54.21M
derived: sum of 2 quarters · filed 2018-05-08
-$79.46M
derived: sum of 3 quarters · filed 2018-05-08
-$104.16M
derived: sum of 4 quarters · filed 2018-05-08
2016-12-31-$20.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
-$46.22M
derived: sum of 2 quarters · filed 2018-03-13
-$70.92M
derived: sum of 3 quarters · filed 2018-03-13
-$96.37M
10-K · filed 2018-03-13
2016-09-30-$25.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01
-$49.95M
derived: sum of 2 quarters · filed 2017-11-01
-$75.39M
10-Q · filed 2017-11-01
-$97.00M
derived: sum of 4 quarters · filed 2018-03-13
2016-06-30-$24.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07
-$50.15M
10-Q · filed 2017-08-07
-$71.76M
derived: sum of 3 quarters · filed 2018-03-13
-$79.29M
derived: sum of 4 quarters · filed 2018-03-13
2016-03-31-$25.45M
10-Q · filed 2017-05-08
-$47.05M
derived: sum of 2 quarters · filed 2018-03-13
-$54.58M
derived: sum of 3 quarters · filed 2018-03-13
-$75.66M
derived: sum of 4 quarters · filed 2018-03-13
2015-12-31-$21.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
-$29.14M
derived: sum of 2 quarters · filed 2018-03-13
-$50.21M
derived: sum of 3 quarters · filed 2018-03-13
-$72.92M
10-K · filed 2018-03-13
2015-09-30-$7.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
-$28.61M
derived: sum of 2 quarters · filed 2016-11-03
-$51.32M
10-Q · filed 2016-11-03
-$72.28M
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30-$21.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
-$43.79M
10-Q · filed 2016-08-08
-$64.75M
derived: sum of 3 quarters · filed 2017-03-13
-$83.82M
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31-$22.71M
10-Q · filed 2016-05-09
-$43.68M
derived: sum of 2 quarters · filed 2017-03-13
-$62.74M
derived: sum of 3 quarters · filed 2017-03-13
-$69.95M
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31-$20.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
-$40.03M
derived: sum of 2 quarters · filed 2017-03-13
-$47.24M
derived: sum of 3 quarters · filed 2017-03-13
-$35.36M
10-K · filed 2017-03-13
2014-09-30-$19.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
-$26.27M
derived: sum of 2 quarters · filed 2015-11-09
-$14.40M
10-Q · filed 2015-11-09
-$30.10M
derived: sum of 4 quarters · filed 2016-03-09
2014-06-30-$7.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$4.67M
10-Q · filed 2015-08-06
-$11.04M
derived: sum of 3 quarters · filed 2016-03-09
2014-03-31$11.88M
10-Q · filed 2015-04-28
-$3.83M
derived: sum of 2 quarters · filed 2016-03-09
2013-12-31-$15.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09
-$53.73M
10-K · filed 2016-03-09
2013-09-30-$38.03M
10-Q · filed 2014-11-06
2012-12-31$44.15M
10-K · filed 2015-03-12